Last reviewed 2026-05-15 · How we verify

Aleph influenza vaccine

Beijing Center for Disease Control and Prevention · FDA-approved active Biologic

Aleph influenza vaccine is a vaccine Biologic drug developed by Beijing Center for Disease Control and Prevention. It is currently FDA-approved for Influenza prevention in adults and children.

Aleph influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains.

Aleph influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains. Used for Influenza prevention in adults and children.

At a glance

Generic name	Aleph influenza vaccine
Sponsor	Beijing Center for Disease Control and Prevention
Drug class	vaccine
Modality	Biologic
Therapeutic area	Immunology
Phase	FDA-approved

Mechanism of action

As an influenza vaccine, it contains inactivated or attenuated influenza virus antigens that train the adaptive immune system to recognize and respond to circulating influenza strains. Upon exposure to wild-type influenza virus, vaccinated individuals mount a faster and more robust immune response, reducing infection severity and transmission risk.

Approved indications

Influenza prevention in adults and children

Common side effects

Injection site pain or erythema
Myalgia
Headache
Low-grade fever

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Aleph influenza vaccine CI brief — competitive landscape report
Aleph influenza vaccine updates RSS · CI watch RSS
Beijing Center for Disease Control and Prevention portfolio CI

Frequently asked questions about Aleph influenza vaccine

What is Aleph influenza vaccine?

Aleph influenza vaccine is a vaccine drug developed by Beijing Center for Disease Control and Prevention, indicated for Influenza prevention in adults and children.

How does Aleph influenza vaccine work?

Aleph influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains.

What is Aleph influenza vaccine used for?

Aleph influenza vaccine is indicated for Influenza prevention in adults and children.

Who makes Aleph influenza vaccine?

Aleph influenza vaccine is developed and marketed by Beijing Center for Disease Control and Prevention (see full Beijing Center for Disease Control and Prevention pipeline at /company/beijing-center-for-disease-control-and-prevention).

What drug class is Aleph influenza vaccine in?

Aleph influenza vaccine belongs to the vaccine class. See all vaccine drugs at /class/vaccine.

What development phase is Aleph influenza vaccine in?

Aleph influenza vaccine is FDA-approved (marketed).

What are the side effects of Aleph influenza vaccine?

Common side effects of Aleph influenza vaccine include Injection site pain or erythema, Myalgia, Headache, Low-grade fever.

Drug class: All vaccine drugs
Manufacturer: Beijing Center for Disease Control and Prevention — full pipeline
Therapeutic area: All drugs in Immunology
Indication: Drugs for Influenza prevention in adults and children
Compare: Aleph influenza vaccine vs similar drugs
Pricing: Aleph influenza vaccine cost, discount & access